1771. A Novel Approach to Distributing COVID-19 Oral Antivirals During a Public Health Emergency Using a Pharmacy Home Delivery Model in New York City, 2022

BACKGROUND: In December 2021, the oral antivirals (OAVs) nirmatrelvir/ritonavir and molnupiravir were authorized for the treatment of COVID-19 in high-risk patients. Initial supplies were limited and states designated pharmacies to receive OAVs from a weekly federal allocation. New York City (NYC) h...

Descripción completa

Detalles Bibliográficos
Autores principales: Foote, Mary M K, Navarro, Elizabeth Diago, Silverstein, Matthew, Shanmugarajah, Niroshan, Eddy, Meredith, Lall, Ramona, Amiel, Pierre J, Cheng, Iris, Kennedy, Joseph, Chan, Hiu Tai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678314/
http://dx.doi.org/10.1093/ofid/ofad500.1601

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678314/
http://dx.doi.org/10.1093/ofid/ofad500.1601

Ejemplares similares